Tag: Announces

Web Marketing Association Announces the Winners of the 2024 Internet Advertising Competition Awards

Boston, MA, April 03, 2024 –(PR.com)– The Web Marketing Association announces the winners of its 22nd annual Internet Advertising Competition (IAC) Awards, to honor excellence in online advertising and to recognize the individuals and organizations responsible for the best in Internet marketing. The IAC Awards are the first and only industry-based advertising award competition dedicated exclusively to online advertising. The Competition web site with a complete list of winners is located at www.IACAward.org

“At a time when everyone could use a morale boost, the winners of the 22nd annual Internet Advertising Competition (IAC) Awards represent the best in online advertising in 86 industries and 10 advertising formats,” said William Rice, president of the Web Marketing Association, Inc. “The Web Marketing Association is pleased to help set the standard for Internet excellence with the IAC Awards by highlight the best in online advertising by medium and industry.”

Best of Show Winners

These Best of Show winners represent the pinnacle of achievement across all industries. The Web Marketing Association is pleased to help set the standard for Internet excellence with the IAC Awards by highlighting the best in online advertising by medium and industry.

Here are this year’s Best of Show winners:

Infillion and Rufus for Amazon, winner of Best of Show Online Ad

Sanky Communications for African Wildlife Foundation Congo Basin, winner of Best of Show Online Campaign

Most Likely To for SF Climate Action Plan, winner of Best of Show Online Video Campaign

The Heist for It Was There All Along – Original Animation, winner of Best of Show Online Video

Data Axle and Marriott International for Marriott Bonvoy Inspires Travel with Design, Imagery and Animation, winner of Best of Show Online Newsletter Campaign

Ad Cucina for Biscuit Belly e-mail campaign, winner of Best of Show Email Campaign

Zeta Global

Read More ...

Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights

Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced financial results for the year ended December 31, 2023, and recent business highlights.

“Aerovate reached important milestones in 2023 with the achievement of full enrollment of the Phase 2b portion and the first patient enrolled in the Phase 3 portion of our IMPAHCT trial evaluating AV-101 for patients with PAH,” said Tim Noyes, Chief Executive Officer of Aerovate. “In 2024, we look forward to presenting baseline characteristics of IMPAHCT at the ATS international conference in May, as well as announcing Phase 2b topline data in June with the full Phase 2b clinical trial results to be presented at an upcoming scientific meeting. We remain confident that delivering our proprietary formulation of imatinib directly to the pulmonary vasculature via inhalation has the potential to achieve robust efficacy with a low side effect burden in PAH patients on two or three background therapies. As such, we continue to believe that AV-101 has the potential to be an important part of the future standard of care for PAH patients.”

2023 Highlights

Enrollment Complete and Topline Data Expected in June 2024 from Phase 2b Portion of the IMPAHCT Global Phase 2b/Phase 3 Clinical Trial. IMPAHCT (Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial) is a global Phase 2b/Phase 3 trial of AV-101, our self-administered, twice daily dry powder inhaled formulation of the antiproliferative drug imatinib for the treatment of PAH. PAH is a devastating disease impacting approximately 70,000 people in the United States and Europe. In November 2023, we announced completion of enrollment at 202 adult patients in the Phase 2b portion of the IMPAHCT trial,

Read More ...

Ellington Financial Announces Estimated Book Value Per Common Share as of December 31, 2023

OLD GREENWICH, Conn., February 07, 2024–(BUSINESS WIRE)–Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced its estimated book value per share of common stock of $13.83 as of December 31, 2023.

Cautionary Statement Regarding Forward-Looking Statements

Estimated book value per common share is subject to change upon completion of the Company’s month-end and quarter-end valuation procedures relating to its investment positions, and any such change could be material. There can be no assurance that the Company’s estimated book value per common share as of December 31, 2023 is indicative of what the Company’s results are likely to be for the three-month period or year ending December 31, 2023 or in future periods, and the Company undertakes no obligation to update or revise its estimated book value per common share prior to issuance of financial statements for such periods.

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. The Company’s actual results may differ from its beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements are not historical in nature and can be identified by words such as “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “continue,” “intend,” “should,” “would,” “could,” “goal,” “objective,” “will,” “may,” “seek” or similar expressions or their negative forms, or by references to strategy, plans, or intentions. Forward-looking statements are based on our beliefs, assumptions and expectations of our future operations, business strategies, performance, financial condition, liquidity and prospects, taking into account information currently available to us. These beliefs, assumptions, and expectations are subject to risks and uncertainties and can change as a result of many possible events or factors, not all

Read More ...

Winterberry Group Announces Annual ‘Outlook’ for Estimated

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) — Estimated overall ad spending in U.S. will post a robust 10.4-percent growth in 2024, reaching $570 billion – fueled by $17 billion in political ad spending, and continued transformation of data-driven advertising, from connected television (CTV) to numerous digital ad channels where double-digit percentage growth is expected, according to Winterberry Group which announces today its “Outlook for Advertising, Marketing and Data 2024” research estimates. The new research also includes a recap of 2023 ad spending across online and offline media channels.

The predictions from the strategic consultancy also included a variety of business drivers and trends, from macroeconomic influences such as interest rates and unemployment, to advertising-specific concerns, among them the loss of third-party cookies as reliable household and individual identifiers for advertising, and their attempted replacement by a variety of technologies and techniques. For the 18th consecutive year, the research was announced by Bruce Biegel, senior managing partner, Winterberry Group at a Marketing Club of New York program in New York City.

“Nearly half the projected ad spend growth will be driven by the forthcoming election cycle,” Biegel said, noting that the campaign for U.S. President and Members of Congress – which likely will be divisive – may dampen the ability of brands to connect with consumers, since brands tend to steer clear of ad-financing in media channels where controversy foments. “Still, the investment in data-driven channels will flourish – where spending on data, data services and data infrastructure is predicted to top $36 billion in 2024, a 13.9-percent increase.”

“Another predominant trend is that retail media networks – with impact on display, search and social – are expanding to become ‘commerce media networks,’ where platforms with significant first-party data are leveraged to support targeted, measurable business objectives,” Biegel said.

Read More ...

RE Royalties Announces Third Quarter 2023 Financial Results and Key Business Highlights

All amounts in Canadian dollars unless otherwise stated

VANCOUVER, BC / ACCESSWIRE / November 27, 2023 / RE Royalties Ltd. (TSX.V:RE)(OTCQX:RROYF) (“RE Royalties” or the “Company“), a global leader in renewable energy royalty-based financing, is pleased to announce the financial results for the third quarter ended September 30, 2023 (“Q3 2023“). For further information on these results please see the Company’s Condensed Consolidated Interim Financial Statements and Management’s Discussion and Analysis for Q3 2023, filed on SEDAR+ at www.sedarplus.com.

Key business and financial highlights for Q3 2023 include:

  • The Company entered into a loan agreement and a royalty agreement with Butler Corporation SpA (“CleanLight”), a Chilean technology company and manufacturer of mobile solar-battery systems including solar lighting towers and solar-hybrid battery generators. The Company provided a US$3 million secured loan to finance CleanLight’s expansion into other countries in Latin America. The CleanLight loan has a two-year term, and bears interest of 12% per annum. The Company also acquired a gross revenue royalty of 5% for a period of 10 years, for US$200,000. The royalty rate will reduce to 3% after certain revenue milestones are met.

  • The Company entered into a loan agreement and a royalty agreement with Revolve Renewable Power Corp. (“Revolve”) to support Revolve’s acquisition of a portfolio of two operational run-of-river hydro projects in British Columbia, and one operational wind project in Alberta with a combined gross capacity of 23 MW (the “Operational Projects”).The Operational Projects receive revenue from Power Purchase Agreements (“PPAs”) with BC Hydro and the City of Medicine Hat, for the hydro projects and the wind project, respectively. The Operational Projects have PPAs with remaining terms ranging from 32-35 years for the hydro projects and 11 years for the wind project. The loan will have a term

Read More ...

NUMATEC Announces Winners of the Numees! A Marketing and Advertising Pitch Competition

– $100,000 Have Been Awarded to Four Companies Transforming the World of MarTech –

MIAMI, FL –News Direct– NUMATEC

NUMATEC, the leading independent MarTech conglomerate, held a private event yesterday to announce the winners of the NUMEES (New Marketing & Advertising Technology Award and Pitch Competition). The event recognized four outstanding firms for their work in reimagining advertising and marketing technology, granting $100,000 in monetary investment and consulting services to the winning start-ups. Their achievements were celebrated in Coral Gables on November 14th, featuring influential leaders from Miami’s booming technology ecosystem.

“At NUMATEC, we have a profound understanding of what it takes to build something from the ground up and a deep appreciation for Miami’s tech ecosystem, which nurtured and fueled our growth every step of the way. We’re very committed to playing a meaningful role in this community and helping early-stage companies find their distinct advantage at the forefront of innovation. Part of achieving success is giving back, which is why the NUMEES were designed to help talented entrepreneurs overcome problems and future-proof their business for years to come,” shared NUMATEC CEO Giuliano Stiglitz.

In 2020, 1.35 million technology start-ups launched worldwide, yet only 10% survived as thriving businesses. The NUMEES are designed to bridge this gap and support the growth of tech start-ups to increase their likelihood of success in this challenging technological landscape.

Presented in collaboration with Lab22c, the NUMEES awards were granted in four categories:

– Ángela Sustaita-Ruiz – Nuestro Stories was awarded the Breakthrough Founder of the Year Award, which recognizes innovation in products or services, outstanding customer experience, and market dominance.

– Charles Irizarry – OnAutoPilot – was awarded the Breakthrough Creator Award, which recognizes creative use of emerging technologies, especially artificial intelligence and machine learning, to reinvent the MarTech field.

Read More ...

Lightbridge Provides Business Update and Announces Third Quarter 2023 Financial Results

Lightbridge Corporation

Lightbridge Corporation

Conference Call on Tuesday, October 31 at 4 p.m. ET

RESTON, Va., Oct. 30, 2023 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the third quarter ended September 30, 2023, and provided an update on the Company’s continued progress.

Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented, “We are making excellent progress on our fuel development efforts. Our recently announced engineering study in Romania is an important advancement for examining Lightbridge Fuel’s feasibility in CANDU reactors. Together with our Strategic Partnership Project Agreement with Idaho National Laboratory that we announced in December and the DOE-funded studies at MIT and Texas A&M relating to our fuel for small modular reactors, we continue to advance towards commercial applications in reactors of today and of the future.”

Financial Highlights

The Company maintained a working capital position at September 30, 2023 of $28.6 million and had no debt.

Cash Flows Summary

Cash and cash equivalents were $29.2 million, as compared to $28.9 million at December 31, 2022, an increase of $0.3 million for the nine months ended September 30, 2023, consisting of the following:

  • Cash used in operating activities for the nine month periods ended September 30, 2023 and September 30, 2022 was $4.1 million.

  • Cash provided by financing activities for the nine months ended September 30, 2023, was $4.5 million, a decrease of $6.1 million compared to $10.6 million in the nine months ended September 30, 2022. This decrease was due to a decrease in the net proceeds from the issuance of common stock by our at-the-market (ATM) facility in the first nine months of 2023.

Balance Sheet Summary
Total assets were $30.1 million, and total liabilities were $0.9 million at September 30, 2023. Working capital was $28.6

Read More ...

Ellington Financial Announces Estimated Book Value Per Common Share as of September 30, 2023

OLD GREENWICH, Conn., October 25, 2023–(BUSINESS WIRE)–Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced its estimated book value per share of common stock of $14.33 as of September 30, 2023. This estimate includes the effect of the previously announced monthly dividend of $0.15 per share of common stock, payable on October 25, 2023 to holders of record on September 29, 2023, with an ex-dividend date of September 28, 2023.

Cautionary Statement Regarding Forward-Looking Statements

Estimated book value per common share is subject to change upon completion of the Company’s month-end and quarter-end valuation procedures relating to its investment positions, and any such change could be material. There can be no assurance that the Company’s estimated book value per common share as of September 30, 2023 is indicative of what the Company’s results are likely to be for the three- or nine-month periods ending September 30, 2023 or in future periods, and the Company undertakes no obligation to update or revise its estimated book value per common share prior to issuance of financial statements for such periods.

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. The Company’s actual results may differ from its beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements are not historical in nature and can be identified by words such as “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “continue,” “intend,” “should,” “would,” “could,” “goal,” “objective,” “will,” “may,” “seek” or similar expressions or their negative forms, or by references to strategy, plans, or intentions. Forward-looking statements are based on our beliefs, assumptions and expectations of our future operations, business strategies,

Read More ...

iCubesWire announces tailor-made Innovative Ad Solutions & Influencer Marketing Campaigns ahead of the World Cup & Festive Season

iCubesWire, a global Audience Ad Tech Platform, has announced interactive ad solutions and influencer marketing campaigns tailor-made for the upcoming World Cup and the festive season. The company is set to help brands across industries in amplifying their reach and scoring the most engagement by tapping into the fervour of cricket, a sport celebrated with immense passion in India.

The company is developing custom influencer marketing strategies and interactive ads, to offer brands a competitive edge. By subtly integrating cricket with the brands, iCubesWire ensures a relevant advertising experience for the audience.

Plugging influencer marketing and interactive ads is crucial for brands during high-profile events like the World Cup to build brand recall. By bringing cricket personalities and interactive ads into the picture, brands can engage the sport’s extensive fan base, resulting in significant value increases and high audience reach, as evidenced by the 451 million unique viewers on Star Sports and over 1300 crore video views on platforms like JioCinema during the IPL’23 season.

The interactive and immersive experiences provided by tech-play and smart gadget sensors, along with the credibility of cricket personalities, serve as indispensable tools for brands. These aspects further enhance brand resonance, and long-term loyalty, allowing brands to leave a lasting impression during such events.

Sahil Chopra
Sahil Chopra

Speaking on the announcement, Sahil Chopra, Founder & CEO, iCubesWire, said, “In a country where cricket is almost a religion, leveraging topical events and trends as grand as the World Cup is crucial for brands to connect with the audience on a deeper level. Our innovative ad solutions and influencer marketing campaigns are designed to help brands capitalize on the immense popularity of cricket, allowing them to grab more eyeballs during the World Cup and the upcoming festive season.”

Eshaan Khosla
Eshaan Khosla

Adding further, Eshaan Khosla, Head of

Read More ...

CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES

BEIJING, Aug. 11, 2023 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the quarter ended June 30, 2023. 

Wei-Wu He, Ph.D., CASI’s Chairman and Chief Executive Officer, commented, “We are pleased to report $9.8 million sales revenue for the second quarter of 2023. This is a 15% increase compared to the same period last year and an 18% of increase from the first quarter of 2023.”

Dr. He continued, “Advancement, development, and commercialization of the portfolio remains our strategic focus.  We have achieved a major milestone with our partner Juventas Biotechnology (Tianjin) Co., Ltd. (“Juventas”) on the CNCT-19 CAR-T Cell therapy. CNCT-19’s New Drug Application (NDA) was accepted by National Medical Products Administration (NMPA) in December 2022. We are now diligently preparing for the anticipated CNCT-19 launch in China. We are advancing the clinical development of BI-1206 in combination with rituximab and presently undertaking the enrollment of patients for the second cohort of the phase I trial in China.  We are transitioning the development of CID-103 into China for the malignant hematology indications. In addition, we acquired global rights for CB-5339 from Cleave Therapeutics in July. On August 1st, we announced the transfer of license of Folotyn® in China from Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc.. We continue to advance our portfolio by executing on several milestones as well as bringing in new potential opportunities for synergy in the quarters ahead.”

Second Quarter 2023 Financial Highlights

  • Revenue was $9.8 million for the three months ended June 30, 2023, compared to $8.6 million for the three months ended June 30, 2022.
  • Costs of revenues were
Read More ...